Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Vistagen Therapeutics, Inc. (VTGN)

Compare
2.3900
+0.0500
+(2.14%)
At close: 4:00:00 PM EDT
2.3800
-0.01
(-0.42%)
After hours: 4:58:30 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
698
1,064
-227
1,108.9000
1,089.5000
Operating Expense
53,535
34,085
59,041
48,655.8000
19,023.7000
Operating Income
-52,837
-33,021
-59,268
-47,546.9000
-17,934.2000
Net Non Operating Interest Income Expense
5,229
3,351
26
20
2
Other Income Expense
--
312
--
-232
0.6000
Pretax Income
-47,296
-29,358
-59,242
-47,759
-17,931.6000
Tax Provision
8
4
6
3.4000
2.6000
Net Income Common Stockholders
-47,304
-29,362
-59,248
-48,707.5000
-42,319.8000
Diluted NI Available to Com Stockholders
-47,304
-29,362
-59,248
-48,707.5000
-42,319.8000
Basic EPS
-1.48
-1.52
-8.51
-7.38
-14.70
Diluted EPS
-1.48
-1.52
-8.51
-7.38
-14.70
Basic Average Shares
30,617.2000
19,354.5000
6,959.4440
6,599.9460
2,871.1210
Diluted Average Shares
30,617.2000
19,354.5000
6,959.4440
6,599.9460
2,871.1210
Total Operating Income as Reported
-52,837
-33,021
-59,268
-47,778.9000
-17,933.8000
Rent Expense Supplemental
--
--
419
377
354
Total Expenses
53,535
34,085
59,041
48,655.8000
19,023.7000
Net Income from Continuing & Discontinued Operation
-47,304
-29,362
-59,248
-47,762.4000
-17,934.2000
Normalized Income
-47,304
-29,362
-59,248
-47,530.6784
-17,934.2000
Interest Income
--
--
49
20
15
Interest Expense
--
--
23
--
13
Net Interest Income
5,229
3,351
26
20
2
EBIT
-52,837
-33,021
-59,268
-47,759
-17,918.6000
EBITDA
-52,221
-32,453
-58,736
-47,047.9000
-17,441
Reconciled Depreciation
616
568
532
711.1000
477.6000
Net Income from Continuing Operation Net Minority Interest
-47,304
-29,362
-59,248
-47,762.4000
-17,934.2000
Total Unusual Items Excluding Goodwill
--
--
--
-232
--
Total Unusual Items
--
--
--
-232
--
Normalized EBITDA
-52,221
-32,453
-58,736
-46,815.9000
-17,441
Tax Rate for Calcs
0.0002
--
--
0
--
Tax Effect of Unusual Items
--
--
--
-0.2784
--
3/31/2021 - 6/21/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XBIO Xenetic Biosciences, Inc.
2.6700
+7.23%
 
ABOS Acumen Pharmaceuticals, Inc.
1.0800
+0.47%
 
TRVN Trevena, Inc.
1.2800
+1.59%
 
ADIL Adial Pharmaceuticals, Inc.
0.6900
+5.18%
 
ITOS iTeos Therapeutics, Inc.
5.77
+2.49%
 
SVRA Savara Inc.
3.0100
+5.24%
 
PASG Passage Bio, Inc.
0.3910
+1.77%
 
TSBX Turnstone Biologics Corp.
0.3798
+0.26%
 
ENSC Ensysce Biosciences, Inc.
2.6400
+5.60%
 
VTVT vTv Therapeutics Inc.
17.50
+6.71%